Article

Low and Ultra-low HER2 in Human Breast Cancer: An Effort to Define New Neoplastic Subtypes

2023-06-23

Abstract excerpt

HER2-low and ultra-low breast cancer (BC) have been recently proposed as new subcategories of HER2 BC, re-considering the immunohistochemical negative score of 0, 1+ or score of 2+/in situ hybridization (ISH) negative phenotype. In the present review we have outlined the needed criteria to exactly distinguish HER2 low and ultra-low BC. Recent clinical trials have demonstrated significant clinical benefits of novel...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b84ba077-e271-5601-a259-64fe3f7c9c32
DOI: 10.20944/preprints202306.1670.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Low and Ultra-low HER2 in Human Breast Cancer: An Effort to Define New Neoplastic SubtypesDOI 10.20944/preprints202306.1670.v1Read

Low and Ultra-Low HER2 in Human Breast Cancer: An Effort to Define New Neoplastic Subtypes.Semantic proximity Read

HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast CancerSemantic proximity Read

The trichotomy of HER2 expression confers new insights into the understanding and managing for breast cancer stratified by HER2 statusSemantic proximity Read

Clinicopathological features and prognosis of HER2 low-expression breast cancer: a single-center retrospective studySemantic proximity Read

Response to trastuzumab-deruxtecan in metastatic triple-negative breast cancer with both HER2 mutation and low expression.Semantic proximity Read

Unveiling the mysteries of HER2-low expression in breast cancer: pathological response, prognosis, and expression level alterationsSemantic proximity Read

Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond.Semantic proximity Read

Advances in EGFR/HER2-directed clinical research on breast cancer.Semantic proximity Read

Dissecting the biological heterogeneity of HER2-positive breast cancerSemantic proximity Read

Clinicopathological Characterization of HER2-Low-Expressing Triple-Negative Breast Cancer: Distinct Features From HER2-Zero Subtype.Semantic proximity Read

Impact of HER2-low Breast Cancer on Survival in Denmark: A Nationwide Investigation (2007-2019)Semantic proximity Read

Molecular and Clinical Portrait of HER2-low Invasive Lobular Carcinomas.Semantic proximity Read